| 1 |
Cirillo F. Neuroendocrine tumors and their association with rare tumors: observation of 4 cases. Eur Rev Med Pharmacol Sci, 2010, 14(7): 577-588. 577-588.
|
| 2 |
Dong RZ, Shi YQ, Ye YW, et al. Clinicopathological and prognostic analysis of 23 poorly differentiated neuroendocrine carcinomas of the stomach. Zhonghua Wei Chang Wai Ke Za Zhi, 2010, 13(8): 583-586.
|
| 3 |
Massironi S, Sciola V, Peracchi M, et al. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol, 2008, 14(35): 5377-5384.
|
| 4 |
Fenoglio-Preiser CM. Gastrointestinal neuroendocrine/neuroectodermal tumors. Am J Clin Pathol 2001, 115 Suppl: S79-S93.
|
| 5 |
Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology, 2005, 128(7): 1717-1751.
|
| 6 |
Shida T, Furuya M, Nikaido T, et al. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas. Clin Cancer Res, 2005, 11(2 Pt 1): 450-458.
|
| 7 |
Dumoulein M, Verslype C, van Cutsem E, et al. Carcinoid heart disease: case and literature review. Acta Cardiol, 2010, 65(2): 261-264.
|
| 8 |
Dero I, De Pauw M, Borbath I, et al. Carcinoid heart disease--a hidden complication of neuroendocrine tumours. Acta Gastroenterol Belg, 2009, 72(1): 34-38.
|
| 9 |
Glinicki P, Jeske W. Chromogranin A (CgA)--the influence of various factors in vivo and in vitro, and existing disorders on it's concentration in blood. Endokrynol Pol, 2010, 61(4): 384-387.
|
| 10 |
Tota B, Angelone T, Mazza R, et al. The chromogranin A-derived vasostatins: new players in the endocrine heart. Curr Med Chem, 2008, 15(14): 1444-1451.
|